|
US2005136088A1
|
|
Use of bacterial phage associated lysing enzymes for treating various illnesses
|
|
CA2513571A1
|
|
The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
|
|
AU2003279247A1
|
|
The use of bacterial phage associated lysing proteins for treating bacterial dental caries
|
|
EP1501925A2
|
|
Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis
|
|
WO03024410A2
|
|
Composition for treating streptococcus pneumoniae
|
|
ZA200205590B
|
|
The parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections.
|
|
US6733749B2
|
|
Throat lozenges for the treatment of Hemosphilus influenza
|
|
WO02102405A1
|
|
The use of bacterial phage associated lytic enzymes to prevent food poisoning
|
|
IL150675D0
|
|
The parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
|
|
US6399098B1
|
|
Composition for treating dental caries caused by streptococcus mutans
|
|
US6326002B1
|
|
Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract
|
|
US6428784B1
|
|
Vaginal suppository for treating group B Streptococcus infection
|
|
US6406692B1
|
|
Composition for treatment of an ocular bacterial infection
|
|
US6432444B1
|
|
Use of bacterial phage associated lysing enzymes for treating dermatological infections
|
|
US6277399B1
|
|
Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections
|
|
US6399097B1
|
|
Composition for treatment of a bacterial infection of the digestive tract
|
|
US6395504B1
|
|
Use of phage associated lytic enzymes for the rapid detection of bacterial contaminants
|
|
US6254866B1
|
|
Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract
|
|
US6056954A
|
|
Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
|
|
US5997862A
|
|
Therapeutic treatment of group A streptococcal infections
|
